WHEN TOPICALS AREN'T ENOUGH, ASK FOR SOTYKTU

Ready to treat your moderate to severe plaque psoriasis from the inside?

Actor portrayal of a SOTYKTU® patient looking over her shoulder, smiling.

ASK ABOUT SOTYKTU, A CHANCE TO FIND CLEARER SKIN AT 16 WEEKS*

 SOTYKTU® once-daily pill winking face mascot.

CLEARER SKIN for nearly TWICE AS MANY PEOPLE vs Otezla® (apremilast), at 24 weeks

.

RESULTS THAT CAN LAST
Majority of people saw 75% clearer skin at Years 1 and 5

Just ONE PILL, taken once a day

SOTYKTU was studied among 1684 adults in two large clinical trials. 841 received SOTYKTU, 422 received Otezla® (apremilast), and 421 received placebo (a pill with no medicine). Patients were assessed at 16, 24, and 52 weeks.

* In one study, clear or almost clear skin was seen by 50% of people taking SOTYKTU vs 9% taking placebo at 16 weeks. In the same study, 90% clearer skin was seen by 32% of people taking SOTYKTU vs 20% taking Otezla at 24 weeks.
In a second study, 90% clearer skin was seen by 42% of people taking SOTYKTU vs 22% taking Otezla at 24 weeks.
In a follow-up study at 1 year and thereafter, 485 patients received continuous SOTYKTU through 5 years. 72% of people taking SOTYKTU saw 75% clearer skin at 1 year. 67% of people taking SOTYKTU saw 75% clearer skin at 5 years. Patients and physicians were aware of SOTYKTU treatment, which may have influenced their results.
Actor portrayal of a SOTYKTU® patient touching her neck with a smile.

Looking for clearer skin?* See how SOTYKTU performed in clinical trials.

Actor portrayal of a SOTYKTU® patient with a brilliant smile.

If you think it’s time for a change, ask your dermatology specialist these questions.

FINDING SOTYKTU MEANS FINDING SUPPORT

Everyone who's been prescribed SOTYKTU is invited to enroll in SOTYKTU 360 SUPPORT, a program providing:
The Co-Pay Assistance program where eligible, commercially insured patients may pay as little as $0 per month§
Live assistance a phone call away
Tools and info for your mailbox and inbox
§ Eligibility requirements and Co-Pay Assistance Program Terms and Conditions apply.
While support team members can answer questions about SOTYKTU, they cannot provide medical advice.

SO

HERE'S A QUESTION...

Loading...

Real SOTYKTU® patient, Emily, shares her story with SOTYKTU®, an oral medication for moderate to severe plaque psoriasis.

Real SOTYKTU® patient, Emily, shares her story with SOTYKTU®, an oral medication for moderate to severe plaque psoriasis.

Clearly the Moment: Emily’s Story

Learn about Emily’s experience on her path to finding SOTYKTU.

Emily is a real patient on SOTYKTU and was compensated for her time. Your results may vary.



Bristol Myers Squibb corporate website

SOTYKTU, SOTYKTU 360 SUPPORT, and SOTYKTU logo are trademarks of Bristol-Myers Squibb Company.
All other trademarks are property of their respective owners.
© 2025 Bristol-Myers Squibb Company.

This website is intended for U.S. residents 18 years of age or older.

1787-US-2500206 07/25